Peer Reviewed
Drug update
Cholinesterase inhibitors and Alzheimer’s disease
Recent articles on:
Dementia
Dementia
Abstract
Cholinesterase inhibitors may lead to improvement in the symptoms of Alzheimer’s disease, but there is no direct evidence that they alter the long term outcome.
Key Points
What are cholinesterase inhibitors?
Cholinesterase inhibitors block cholinesterases, enzymes that break down acetylcholine in the synaptic space, thereby allowing acetylcholine to act longer on the post-synaptic receptor. Acetylcholine is a major neurotransmitter for memory, attention and concentration.
Purchase the PDF version of this article
Already a subscriber? Login here.